UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 260

Sortiert nach

Pooled Analysis of the Effect of Age on Adjuvant Cisplatin-Based Chemotherapy for Completely Resected Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2008-07, Vol.26 (21), p.3573-3581

2008

Link zum Volltext

Verfügbarkeit prüfen

Solitary Fibrous Tumor of the Pleura: Outcomes of 157 Complete Resections in a Single Center

The Annals of thoracic surgery, 2012-08, Vol.94 (2), p.394-400

2012

Link zum Volltext

Verfügbarkeit prüfen

Non-small-cell lung cancer

The Lancet (British edition), 2011-11, Vol.378 (9804), p.1727-1740

2011

Link zum Volltext

Verfügbarkeit prüfen

Prognostic Effect of Tumor Lymphocytic Infiltration in Resectable Non-Small-Cell Lung Cancer

Journal of clinical oncology, 2016-04, Vol.34 (11), p.1223-1230

2016

Link zum Volltext

Verfügbarkeit prüfen

Significance of TP53 mutations as predictive markers of adjuvant cisplatin-based chemotherapy in completely resected non-small-cell lung cancer

Molecular oncology, 2014-05, Vol.8 (3), p.555-564

2014

Link zum Volltext

Verfügbarkeit prüfen

Subtype Classification of Lung Adenocarcinoma Predicts Benefit From Adjuvant Chemotherapy in Patients Undergoing Complete Resection

Journal of clinical oncology, 2015-10, Vol.33 (30), p.3439-3446

2015

Link zum Volltext

Verfügbarkeit prüfen

ERCC1 Isoform Expression and DNA Repair in Non–Small-Cell Lung Cancer

The New England journal of medicine, 2013-03, Vol.368 (12), p.1101-1110

2013

Link zum Volltext

Verfügbarkeit prüfen

Long-Term Results of the International Adjuvant Lung Cancer Trial Evaluating Adjuvant Cisplatin-Based Chemotherapy in Resected Lung Cancer

Journal of clinical oncology, 2010-01, Vol.28 (1), p.35-42

2010

Link zum Volltext

Verfügbarkeit prüfen

Lung Adjuvant Cisplatin Evaluation: A Pooled Analysis by the LACE Collaborative Group

Journal of clinical oncology, 2008-07, Vol.26 (21), p.3552-3559

2008

Link zum Volltext

Verfügbarkeit prüfen

Subclavian Artery Resection and Reconstruction for Thoracic Inlet Cancer: 25 Years of Experience

The Annals of thoracic surgery, 2013-09, Vol.96 (3), p.983-989

2013

Link zum Volltext

Verfügbarkeit prüfen

DNA Repair by ERCC1 in Non–Small-Cell Lung Cancer and Cisplatin-Based Adjuvant Chemotherapy

The New England journal of medicine, 2006-09, Vol.355 (10), p.983-991

2006

Link zum Volltext

Verfügbarkeit prüfen

10-year long-term survival of a metastatic EGFR-mutated nonsmall cell lung cancer patient

The European respiratory journal, 2015-07, Vol.46 (1), p.280-282

2015

Link zum Volltext

Verfügbarkeit prüfen

Cutaneous side-effects of kinase inhibitors and blocking antibodies

The lancet oncology, 2005-07, Vol.6 (7), p.491-500

2005

Link zum Volltext

Verfügbarkeit prüfen

Successful Tracheal Replacement in Humans Using Autologous Tissues: An 8-Year Experience

The Annals of thoracic surgery, 2013-10, Vol.96 (4), p.1146-1155

2013

Link zum Volltext

Verfügbarkeit prüfen

Small-Cell Carcinoma in the Setting of Pulmonary Adenocarcinoma: New Insights in the Era of Molecular Pathology

Journal of thoracic oncology, 2013-10, Vol.8 (10), p.1265-1271

2013

Link zum Volltext

Verfügbarkeit prüfen

Adjuvant Cisplatin and Vinorelbine for Completely Resected Non-small Cell Lung Cancer: Subgroup Analysis of the Lung Adjuvant Cisplatin Evaluation

Journal of thoracic oncology, 2010-02, Vol.5 (2), p.220-228

2010

Link zum Volltext

Verfügbarkeit prüfen

Should surgery be part of the multimodality treatment for stage IIIB non‐small cell lung cancer?

Journal of surgical oncology, 2018-06, Vol.117 (7), p.1570-1574

2018

Link zum Volltext

Verfügbarkeit prüfen

Erlotinib for Frontline Treatment of Advanced Non–Small Cell Lung Cancer: a Phase II Study

Clinical cancer research, 2006-10, Vol.12 (20), p.6049-6055

2006

Link zum Volltext

Verfügbarkeit prüfen

Adjuvant Chemotherapy in Completely Resected Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2005-05, Vol.23 (14), p.3270-3278

2005

Link zum Volltext

Verfügbarkeit prüfen

MutS Homologue 2 and the Long-term Benefit of Adjuvant Chemotherapy in Lung Cancer

Clinical cancer research, 2010-02, Vol.16 (4), p.1206-1215

2010

Link zum Volltext

Verfügbarkeit prüfen

LACE-Bio: Validation of Predictive and/or Prognostic Immunohistochemistry/Histochemistry-based Biomarkers in Resected Non–small-cell Lung Cancer

Clinical lung cancer, 2019-03, Vol.20 (2), p.66-73.e6

2019

Link zum Volltext

Verfügbarkeit prüfen

Treatment of Advanced Non–Small-Cell Lung Cancer in the Elderly: Results of an International Expert Panel

Journal of clinical oncology, 2005-05, Vol.23 (13), p.3125-3137

2005

Link zum Volltext

Verfügbarkeit prüfen

Phase II Clinical Trial of the Epothilone B Analog, Ixabepilone, in Patients With Non–Small-Cell Lung Cancer Whose Tumors Have Failed First-Line Platinum-Based Chemotherapy

Journal of clinical oncology, 2007-08, Vol.25 (23), p.3448-3455

2007

Link zum Volltext

Verfügbarkeit prüfen

Survival of Patients With Resected N2 Non–Small-Cell Lung Cancer: Evidence for a Subclassification and Implications

Journal of clinical oncology, 2000-08, Vol.18 (16), p.2981-2989

2000

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 260

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(230)
Mit Volltextzugriff
(239)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(153)
Science & Technology
(152)
Life Sciences & Biomedicine
(147)
Oncology
(105)
Female
(84)
Male
(79)
Biological And Medical Sciences
(75)
Lung Neoplasms - Drug Therapy
(75)
Medical Sciences
(75)
Middle Aged
(75)
Aged
(66)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(62)
Adult
(57)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(55)
Lung Neoplasms - Pathology
(45)
Carcinoma, Non-Small-Cell Lung - Pathology
(37)
Lung Neoplasms - Mortality
(36)
Treatment Outcome
(36)
Chemotherapy
(34)
Chemotherapy, Adjuvant
(34)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Pooled Analysis of the Effect of Age on Adjuvant Cisplatin-Based Chemotherapy for Completely Resected Non–Small-Cell Lung Cancer

Solitary Fibrous Tumor of the Pleura: Outcomes of 157 Complete Resections in a Single Center

Non-small-cell lung cancer

Prognostic Effect of Tumor Lymphocytic Infiltration in Resectable Non-Small-Cell Lung Cancer

Significance of TP53 mutations as predictive markers of adjuvant cisplatin-based chemotherapy in completely resected non-small-cell lung cancer

Subtype Classification of Lung Adenocarcinoma Predicts Benefit From Adjuvant Chemotherapy in Patients Undergoing Complete Resection

ERCC1 Isoform Expression and DNA Repair in Non–Small-Cell Lung Cancer

Long-Term Results of the International Adjuvant Lung Cancer Trial Evaluating Adjuvant Cisplatin-Based Chemotherapy in Resected Lung Cancer

Pooled Analysis of the Prognostic and Predictive Effects of KRAS Mutation Status and KRAS Mutation Subtype in Early-Stage Resected Non–Small-Cell Lung Cancer in Four Trials of Adjuvant Chemotherapy

Lung Adjuvant Cisplatin Evaluation: A Pooled Analysis by the LACE Collaborative Group

Subclavian Artery Resection and Reconstruction for Thoracic Inlet Cancer: 25 Years of Experience

DNA Repair by ERCC1 in Non–Small-Cell Lung Cancer and Cisplatin-Based Adjuvant Chemotherapy

10-year long-term survival of a metastatic EGFR-mutated nonsmall cell lung cancer patient

Cutaneous side-effects of kinase inhibitors and blocking antibodies

Successful Tracheal Replacement in Humans Using Autologous Tissues: An 8-Year Experience

Small-Cell Carcinoma in the Setting of Pulmonary Adenocarcinoma: New Insights in the Era of Molecular Pathology

Adjuvant Cisplatin and Vinorelbine for Completely Resected Non-small Cell Lung Cancer: Subgroup Analysis of the Lung Adjuvant Cisplatin Evaluation

Should surgery be part of the multimodality treatment for stage IIIB non‐small cell lung cancer?

Erlotinib for Frontline Treatment of Advanced Non–Small Cell Lung Cancer: a Phase II Study

Adjuvant Chemotherapy in Completely Resected Non–Small-Cell Lung Cancer

MutS Homologue 2 and the Long-term Benefit of Adjuvant Chemotherapy in Lung Cancer

LACE-Bio: Validation of Predictive and/or Prognostic Immunohistochemistry/Histochemistry-based Biomarkers in Resected Non–small-cell Lung Cancer

Treatment of Advanced Non–Small-Cell Lung Cancer in the Elderly: Results of an International Expert Panel

Phase II Clinical Trial of the Epothilone B Analog, Ixabepilone, in Patients With Non–Small-Cell Lung Cancer Whose Tumors Have Failed First-Line Platinum-Based Chemotherapy

Survival of Patients With Resected N2 Non–Small-Cell Lung Cancer: Evidence for a Subclassification and Implications

Suchergebnisse filtern